Creo Pharma, founded in 2007, is a specialized pharmaceutical company focused on providing generic medicines, commercial brands, and specialist supply products for the pharmacy, hospital, and wholesale sectors. Formerly a subsidiary of Amneal Pharmaceuticals Group until 2019, it has since become a part of Zentiva. The company's core philosophy revolves around prioritizing customers and supply partners, showcasing their commitment to service. Creo Pharma's UK operations are centered on two key areas: offering alternative brands and niche generics for open prescriptions in the commercial pharmaceutical arena, and supplying specific unlicensed and "off-label" products directly to retail and hospital pharmacies. Furthermore, they provide an out-of-hours emergency service for critical medicine supply. Creo Pharma's dedication to expanding their product pipeline ensures customers have access to an evolving range of innovative medicines and specialist generics. This aligns with their goal to keep pace with the changing market demands, reinforcing their reputation as a flexible and customer-oriented firm. For potential collaborations and supply opportunities in the UK market, interested parties are encouraged to contact [email protected].
There is no investment information
No recent news or press coverage available for Creo Pharma.